Virtual screening-molecular docking-activity evaluation of Ailanthus altissima (Mill.) swingle bark in the treatment of ulcerative colitis

• Published in: BMC complementary and alternative medicine 2023-06, Vol.23 (1), p.197-197, Article 197
• Main Authors: Ma, Shan-Bo, Liu, Lun, Li, Xiang, Xie, Yan-Hua, Shi, Xiao-Peng, Wang, Si-Wang
• Format: Article
• Language: English
• Subjects: Ailanthus altissima; Ailanthus altissima (Mill.) Swingle Bark; Analysis; Animal research; Anti-inflammatory agents; bark; Binding; Cell proliferation; Chinese medicine; complement; computer software; Cytotoxicity; Disease; Epidermal growth factor receptors; Evaluation; Growth factors; Health aspects; Herbal medicine; humans; Hydrogenation; inflammation; Inflammatory bowel disease; Inflammatory bowel diseases; Ingredients; Interleukin 1 receptors; Kaempferol; Ligands; Lipopolysaccharides; Medicine, Chinese; Molecular Docking; Nitric oxide; Oriental traditional medicine; Pharmacodynamics; Pharmacology; Protein binding; Proteins; Research centers; Screening; Software; Technology assessment; therapeutics; Traditional Chinese medicine; Ulcerative Colitis; Virtual screening; Wnt protein
• ISSN: 2662-7671; 2662-7671; 1472-6882
• DOI: 10.1186/s12906-023-03991-0

The dried bark of Ailanthus altissima (Mill.) Swingle is widely used in traditional Chinese medicine for the treatment of ulcerative colitis. The objective of this study was to explore the therapeutic basis of the dried bark of Ailanthus altissima (Mill.) Swingle for the treatment of ulcerative colitis based on Virtual Screening-Molecular Docking-Activity Evaluation technology. By searching the Traditional Chinese Medicine Systems Pharmacology TCMSP Database and Analysis Platform, 89 compounds were obtained from the chemical components of the dried bark of Ailanthus altissima (Mill.) Swingle. Then, after preliminarily screening the compounds based on Lipinski's rule of five and other relevant conditions, the AutoDock Vina molecular docking software was used to evaluate the affinity of the compounds to ulcerative colitis-related target proteins and their binding modes through use of the scoring function to identify the best candidate compounds. Further verification of the compound's properties was achieved through in vitro experiments. Twenty-two compounds obtained from the secondary screening were molecularly docked with ulcerative colitis-related target proteins (IL-1R, TLR, EGFR, TGFR, and Wnt) using AutoDock Vina. The free energies of the highest scoring compounds binding to the active cavity of human IL-1R, TLR, EGFR, TGFR, and Wnt proteins were - 8.7, - 8.0, - 9.2, - 7.7, and - 8.5 kcal/mol, respectively. The potential compounds, dehydrocrebanine, ailanthone, and kaempferol, were obtained through scoring function and docking mode analysis. Furthermore, the potential compound ailanthone (1, 3, and 10 µM) was found to have no significant effect on cell proliferation, though at 10 µM it reduced the level of pro-inflammatory factors caused by lipopolysaccharide. Among the active components of the dried bark of Ailanthus altissima (Mill.) Swingle, ailanthone plays a major role in its anti-inflammatory properties. The present study shows that ailanthone has advantages in cell proliferation and in inhibiting of inflammation, but further animal research is needed to confirm its pharmaceutical potential.